Best Roses Biotech Profile
Key Indicators
- Authorised Capital ₹ 8.50 Cr
as on 06-07-2024
- Paid Up Capital ₹ 8.14 Cr
as on 06-07-2024
- Company Age 22 Year, 10 Months
- Last Filing with ROC 31 Mar 2016
- Open Charges ₹ 9.90 Cr
as on 06-07-2024
- Satisfied Charges ₹ 13.15 Cr
as on 06-07-2024
- Revenue -1.22%
(FY 2016)
- Profit -937.03%
(FY 2016)
- Ebitda -477.91%
(FY 2016)
- Net Worth -1.24%
(FY 2016)
- Total Assets -1.15%
(FY 2016)
About Best Roses Biotech
The Corporate was formerly known as Best Roses Biotech Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2016. It's a company limited by shares with an authorized capital of Rs 8.50 Cr and a paid-up capital of Rs 8.14 Cr.
The company currently has active open charges totaling ₹9.90 Cr. The company has closed loans amounting to ₹13.15 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kumar Patel, Deepak Patel, and Bhavesh Patel serve as directors at the Company.
- CIN/LLPIN
U01122GJ2002PLC040477
- Company No.
040477
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
18 Feb 2002
- Date of AGM
30 Sep 2016
- Date of Balance Sheet
31 Mar 2016
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Navsari, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Best Roses Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhavesh Patel  | Director | Current | |
Kumar Patel  | Director | 18-Feb-2002 | Current |
| Deepak Patel | Director | 18-Feb-2002 | Current |
Financial Performance of Best Roses Biotech.
Best Roses Biotech Limited, for the financial year ended 2016, experienced Minor drop in revenue, with a 1.22% decrease. The company also saw a substantial fall in profitability, with a 937.03% decrease in profit. The company's net worth dipped by a decrease of 1.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Best Roses Biotech?
In 2016, Best Roses Biotech had a promoter holding of 94.08% and a public holding of 5.92%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Gujarat Eco Microbial Technologies Private LimitedActive 21 years 7 monthsBhavesh Patel is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Bank Creation Date: 24 Nov 2006 | ₹9.80 Cr | Open |
Indian Overseas Bank Creation Date: 04 Aug 2004 | ₹1.00 M | Open |
State Bank Of Saurashtra Creation Date: 17 Jun 1993 | ₹13.15 Cr | Satisfied |
How Many Employees Work at Best Roses Biotech?
Unlock and access historical data on people associated with Best Roses Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Best Roses Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Best Roses Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
